Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

被引:60
作者
Miller, George [2 ]
Socci, Nicholas D. [3 ]
Dhall, Deepti [4 ]
D'Angelica, Michael [1 ]
DeMatteo, Ronald P. [1 ]
Allen, Peter J. [1 ]
Singh, Bhuvanesh [1 ]
Fong, Yuman [1 ]
Blumgart, Leslie H. [1 ]
Klimstra, David S. [4 ]
Jarnagin, William R. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] New York Univ, Sch Med, Dept Surg & Cell Biol, New York, NY 10016 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
GROWTH-FACTOR-RECEPTOR; GALLBLADDER CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; MICROSATELLITE INSTABILITY; GENETIC ALTERATIONS; UP-REGULATION; RISK-FACTORS; EXPRESSION; OVEREXPRESSION; PATHWAY;
D O I
10.1186/1756-9966-28-62
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The pathogenesis of biliary cancers is ill-defined. This study investigates changes in gene expression and copy number in biliary cancers and correlates these changes with anatomical site of origin, histopathology and outcome. Methods: We performed gene expression and CGH analysis on 34 biliary tract cancer specimens. Results were confirmed by RT-PCR. Clinical-pathologic correlation was made using functional over-representation analysis of the top 100 mutations associated with each variable. Results: There were 545 genes with altered expression in extrahepatic cholangiocarcinoma, 2,354 in intrahepatic cholangiocarcinoma, and 1,281 in gallbladder cancer. Unsupervised hierarchical clustering analysis indicated there was no difference in the global gene expression patterns between each biliary cancer subgroup. CGH analysis revealed that short segments of chromosomes 1p, 3p, 6q, 8p, 9p, and 14q were commonly deleted across all cancer subtypes. Commonly amplified regions included segments of 1q, 3q, 5p, 7p, 7q, 8q, and 20q. Over-representation analysis revealed an association between altered expression of functional gene groupings and pathologic features. Conclusion: This study defined regions of the genome associated with changes in DNA copy number and gene expression in specific subtypes of biliary cancers. The findings have implications for identification of therapeutic targets, screening, and prognostication.
引用
收藏
页数:13
相关论文
共 26 条
[1]  
Benckert C, 2003, CANCER RES, V63, P1083
[2]  
Chang HJ, 1999, MODERN PATHOL, V12, P763
[3]   Targeting ubiquitin in cancers [J].
Dikic, Ivan ;
Crosetto, Nicola ;
Calatroni, Silvia ;
Bernasconi, Paolo .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (18) :3095-3102
[4]  
Dowlati A, 2004, MOL CANCER THER, V3, P459
[5]   ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions [J].
Endo, K ;
Yoon, BI ;
Pairojkul, C ;
Demetris, AJ ;
Sirica, AE .
HEPATOLOGY, 2002, 36 (02) :439-450
[6]   Ubiquitin and ubiquitin-like proteins in cancer pathogenesis [J].
Hoeller, Daniela ;
Hecker, Christina-Maria ;
Dikic, Ivan .
NATURE REVIEWS CANCER, 2006, 6 (10) :776-788
[7]   Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholanglocarcinoma cells [J].
Isomoto, H ;
Kobayashi, S ;
Werneburg, NW ;
Bronk, SF ;
Guicciardi, ME ;
Frank, DA ;
Gores, GJ .
HEPATOLOGY, 2005, 42 (06) :1329-1338
[8]   Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: Correlation with anatomic site, pathologic variables, and clinical outcome [J].
Jarnagin, WR ;
Klimstra, DS ;
Hezel, M ;
Gonen, M ;
Fong, YM ;
Roggin, K ;
Cymes, K ;
DeMatteo, RP ;
D'Angelico, M ;
Blumgart, LH ;
Singh, B .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1152-1160
[9]   Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J].
Jarnagin, WR ;
Fong, Y ;
DeMatteo, RP ;
Gonen, M ;
Burke, EC ;
Bodniewicz, J ;
Youssef, M ;
Klimstra, D ;
Blumgart, LH .
ANNALS OF SURGERY, 2001, 234 (04) :507-517
[10]   Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma - Implications for adjuvant therapeutic strategies [J].
Jarnagin, WR ;
Ruo, L ;
Little, SA ;
Klimstra, D ;
D'Angelica, M ;
DeMatteo, RP ;
Wagman, R ;
Blumgart, LH ;
Fong, YM .
CANCER, 2003, 98 (08) :1689-1700